Confirmation practice in pharmacogenetic testing; how good is good enough?
نویسندگان
چکیده
منابع مشابه
Translating evidence into practice: how good is good enough?
The birth of the evidence-based medicine (EBM) movement in the early 1990s generated a greater interest in measuring the extent to which scientific knowledge was appropriately applied to therapeutic decisions. Investigators sought to challenge the widespread belief that only a minority of treatments provided to patients were based upon the best available scientific evidence. In 1995 Ellis and c...
متن کاملR factors in Rietveld analysis: How good is good enough?
People mastering Rietveld refinement techniques commonly ask the same questions: What do the various Rietveld discrepancy values, i.e., goodness-of-fit, !2, and R factors mean? Also, which ones are most important? Finally, what values allow one to distinguish good refinements from poor ones? These questions are also important to people who review Rietveld results, as well as individuals trying ...
متن کاملBecause good enough is never good enough
hsr Proceedings in intensive care and cardiovascular anesthesia 2012, Vol. 4 Corresponding author: Prof. Michael John Università Vita-Salute San Raffaele Via Olgettina, 48 20132 Milan, Italy e-mail: [email protected] And now for something completely different. Formula one racing drivers need to know the track they will be speeding around to avoid injuring themselves and others, and hopefully ...
متن کاملQuality of care: how good is good enough?
Israel has made impressive progress in improving performance on key measures of the quality of health care in the community in recent years. These achievements are all the more notable given Israel's modest overall spending on health care and because they have accrued to virtually the entire population of the country.Health care systems in most developed nations around the world find themselves...
متن کاملA therapeutic HIV vaccine: how good is good enough?
The goal of a therapeutic HIV vaccine is to attenuate HIV disease progression in those already infected. Our objective was to establish comparative efficacy and cost-effectiveness thresholds at which a therapeutic vaccine would make a valuable contribution to HIV care. Using an HIV computer simulation model, we compared therapeutic vaccination with HIV standard of care without vaccination. Inpu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinica Chimica Acta
سال: 2019
ISSN: 0009-8981
DOI: 10.1016/j.cca.2018.12.023